Beneficial effects of antioxidant therapy in crush syndrome in a rodent model: enough evidences to be used in humans?

Annals of Intensive Care

卷:8

Patrick M. Honore¹  David De Bels¹  Herbert D. Spapen² 

[1] ICU Department, Centre Hospitalier Universitaire Brugmann;

[2] Universitair Ziekenhuis Brussel, VUB University;

关键词: Astragaloside IV;    Antioxidant therapy;    Rhabdomyolysis;    Crush syndrome;    Ischemia–reperfusion injury;   

DOI  :  10.1186/s13613-018-0431-5

来源: DOAJ

【 授权许可】

Unknown